fulvestrant has been researched along with oxazoles in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Brandt, MR; Cummons, TA; Harris, HA; Leventhal, L; Piesla, MJ; Rogers, KE | 1 |
Akgul, Y; Derk, RC; Meighan, T; Murono, EP; Rao, KM | 1 |
Brandon, NJ; Chen, LY; Gall, CM; Kramár, EA; Liu, F; Lynch, G; Rex, CS | 1 |
Cao, DY; Ji, Y; Tang, B; Traub, RJ | 1 |
Elias, PM; Holleran, WM; Kim, JY; Kim, YI; Lee, YM; Mann, T; Oda, Y; Park, K; Seo, HS; Shin, KO; Uchida, Y | 1 |
Al-Awar, R; Aman, A; Barthel, BL; Cogan, P; Ganesh, AN; Koch, TH; Logie, J; Shoichet, BK; Shoichet, MS | 1 |
Isaacs, C; O'Regan, R; O'Shaughnessy, JA | 1 |
7 other study(ies) available for fulvestrant and oxazoles
Article | Year |
---|---|
An estrogen receptor-beta agonist is active in models of inflammatory and chemical-induced pain.
Topics: Animals; Dose-Response Relationship, Drug; Estradiol; Estrogen Receptor beta; Fulvestrant; Hot Temperature; Hyperalgesia; Inflammation; Male; Oxazoles; Pain; Rats; Rats, Sprague-Dawley | 2006 |
The methoxychlor metabolite, HPTE, directly inhibits the catalytic activity of cholesterol side-chain cleavage (P450scc) in cultured rat ovarian cells.
Topics: Androgen Antagonists; Animals; Benzhydryl Compounds; Catalytic Domain; Cells, Cultured; Cholesterol Side-Chain Cleavage Enzyme; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogens; Female; Flutamide; Fulvestrant; Gene Expression Regulation, Enzymologic; Gonadotropins, Equine; Methoxychlor; Ovary; Oxazoles; Phenols; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Receptors, Estrogen; RNA, Messenger | 2008 |
Cytoskeletal changes underlie estrogen's acute effects on synaptic transmission and plasticity.
Topics: Actins; Age Factors; Analysis of Variance; Animals; Animals, Newborn; Biophysics; Bridged Bicyclo Compounds, Heterocyclic; Cytoskeleton; Dendritic Spines; Dose-Response Relationship, Drug; Electric Stimulation; Estradiol; Estrogen Antagonists; Estrogens; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Female; Fulvestrant; GABA Antagonists; Ginsenosides; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Microscopy, Confocal; Neural Pathways; Neuronal Plasticity; Neurons; Ovariectomy; Oxazoles; Patch-Clamp Techniques; Phenols; Picrotoxin; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Sapogenins; Signal Transduction; Synaptic Transmission; Thiazolidines | 2009 |
Estrogen receptor β activation is antinociceptive in a model of visceral pain in the rat.
Topics: Animals; Disease Models, Animal; Estradiol; Estrogen Receptor beta; Female; Fulvestrant; Nitriles; Nociception; Oxazoles; Phenols; Posterior Horn Cells; Propionates; Rats; Rats, Sprague-Dawley; Visceral Pain | 2012 |
The dietary ingredient, genistein, stimulates cathelicidin antimicrobial peptide expression through a novel S1P-dependent mechanism.
Topics: Antimicrobial Cationic Peptides; Cathelicidins; CCAAT-Enhancer-Binding Protein-alpha; Cells, Cultured; Ceramidases; Estradiol; Estrogen Receptor beta; Fulvestrant; Genistein; Humans; Keratinocytes; Lysophospholipids; Oxazoles; Phenols; Receptors, Calcitriol; Sphingosine | 2014 |
Colloidal Drug Aggregate Stability in High Serum Conditions and Pharmacokinetic Consequence.
Topics: Animals; Antineoplastic Agents; Carbamates; Colloids; Doxorubicin; Drug Stability; Excipients; Female; Fulvestrant; Humans; MCF-7 Cells; Mice; Neoplasm Transplantation; Oxazoles; Polysorbates; Prodrugs; Proof of Concept Study; Serum | 2019 |
Neratinib: an option for HER2-positive metastatic breast cancer.
Topics: Ado-Trastuzumab Emtansine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Clinical Trials as Topic; Disease Management; Female; Fulvestrant; Humans; Neoplasm Metastasis; Oxazoles; Pyridines; Quality of Life; Quinazolines; Quinolines; Receptor, ErbB-2; Trastuzumab | 2020 |